Clinical Trial Update: Mesenchymal Stem Cell Injection in Amyotrophic Lateral Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of mesenchymal stem cell injections for amyotrophic lateral sclerosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Mesenchymal stem cell injection (mesenchymal stem cells)

Snippet

Sponsor: Alzahra Hospital, Iran | Conditions: Amyotrophic Lateral Sclerosis | Phase 1, Phase 2 | Status: WITHDRAWN